Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03253198 · ClinicalTrials.gov registry record · NA
Prospective RCT Comparing Perioperative Pain
A NA study of Arthroplasty Shoulder, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT03253198: Completed NA study of Arthroplasty Shoulder, sponsored by Rothman Institute Orthopaedics.
NCT03253198 is a NA study of Arthroplasty Shoulder that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 156 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03253198, a NA study of Arthroplasty Shoulder, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a non-blinded randomized controlled trial comparing the use of a preoperative "mini" block plus postoperative local infiltration of Exparel (liposomal form of bupivacaine) versus a partial single shot nerve block in subjects undergoing primary reverse or total shoulder arthroplasty to see which is more effective in controlling surgery related pain. To do so, we will utilize the Visual Analog Scale (VAS) to measure pain intensity. Opioid consumption will be recorded on a Pain Monitoring Sheet.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Bupivacaine liposome
Study Locations (1)
Pennsylvania
- Rothman Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT03253198 record still lists
NCT03253198 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Arthroplasty Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT03253198 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03253198 about?
NCT03253198 is a clinical study titled "Prospective RCT Comparing Perioperative Pain". This study is a non-blinded randomized controlled trial comparing the use of a preoperative "mini" block plus postoperative local infiltration of Exparel (liposomal form of bupivacaine) versus a partial single shot nerve block in subjects undergoing primary reverse or total shoulder arthroplasty to ...
What is the current status of trial NCT03253198?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2016-08. Estimated completion is 2017-07.
What conditions does trial NCT03253198 study?
This clinical trial studies the following conditions: Arthroplasty Shoulder.
What interventions are being tested in trial NCT03253198?
The interventions under investigation include: Saline (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT03253198?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03253198 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03253198's enrollment target sits among peer trials
156 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia